NicholasJamesLoweMD

PubMed

• 3 citations
  Randomized, Placebo-Controlled Phase 1/2 Study to Determine the Appropriate ATX-101 Concentration for Reduction of Submental Fat.
  Greg J. Goodman, Lynda J Spelman, Nicholas J. Lowe, Beta Bowen> ;Dermatologic Surgery. 2021 Aug 1
• 5 citations
  Assessment of Natural Sunlight Protection Provided by 10 High-SPF Broad-Spectrum Sunscreens and Sun-Protective Fabrics.
  Shaun N G Hughes, Nicholas J. Lowe, Ken Gross, Leslie Mark, Bernard S. Goffe, Hunter Hughes, Curtis Cole> ;Current Problems in Dermatology. 2021 Jan 1
• 1 citations
  Periorbital Discolouration Diagnosis and Treatment: Evidence-Based Review.
  Maria Katerina Pissaridou, Ali M. Ghanem, Nicholas J. Lowe> ;Journal of Cosmetic and Laser Therapy. 2020 Nov 16
• 4 citations
  Volume restoration of hands with polycaprolactone by cannula delivery; a prospective single center consecutive case series evaluation.
  Nicholas J. Lowe, Ali M. Ghanem> ;Journal of Cosmetic and Laser Therapy. 2020 Jan 31
• 9 citations
  Fractional radiofrequency in the treatment of skin aging: an evidence-based treatment protocol.
  Ileana Afroditi Kleidona, Dimitrios Karypidis, Nicholas J. Lowe, Simon Myers, Ali M. Ghanem> ;Journal of Cosmetic and Laser Therapy. 2020 Jan 1
• 146 citations
  Photodynamic Therapy: A Clinical Consensus Guide.
  David M. Ozog, Ali M. Rkein, Sabrina G. Fabi, Michael H. Gold, Mitchel P. Goldman, Nicholas J. Lowe, George M. Martin, Girish S. Munavalli> ;Dermatologic Surgery. 2016 Jul 1
• 7 citations
  Botulinum toxin type B: pH change reduces injection pain, retains efficacy.
  Philippa Lowe, Nicholas J. Lowe> ;Dermatologic Surgery. 2014 Dec 1
• 9 citations
  Botulinum toxins for facial lines: a concise review.
  Nicholas J. Lowe, Philippa Lowe> ;Dermatology and Therapy. 2012 Sep 29
• 1 citations
  Four methods of evaluation of facial erythema and pigment treated with intense pulsed light or cream.
  Havva Hassan, Nicholas J. Lowe, R.J. Barlow, David A. Harris> ;Journal of Cosmetic and Laser Therapy. 2012 Jun 6
• 7 citations
  Investigator Global Evaluations of Efficacy of Injectable Poly-L-Lactic Acid Versus Human Collagen in the Correction of Nasolabial Fold Wrinkles
  Fredric S Brandt, Alex Cazzaniga, Leslie Baumann, Steven Fagien, Scott Glazer, Jeffrey M. Kenkel, Nicholas J. Lowe, Gary D. Monheit, Rhoda S. Narins, Marta I. Rendon, ...> ;Aesthetic Surgery Journal. 2011 Jul 1
• 5 citations
  Subject global evaluation and subject satisfaction using injectable poly-l-lactic acid versus human collagen for the correction of nasolabial fold wrinkles
  Spencer A. Brown, Rod J. Rohrich, Leslie Baumann, Fredric S Brandt, Steven Fagien, Scott Glazer, Jeffrey M. Kenkel, Nicholas J. Lowe, Gary D. Monheit, Rhoda S. Narins,...> ;Plastic and Reconstructive Surgery. 2011 Apr 1
• 6 citations
  Three-dimensional digital surface imaging measurement of the volumizing effect of injectable poly-L-lactic acid for nasolabial folds.
  Philippa Lowe, Nicholas J. Lowe, Rickie Patnaik> ;Journal of Cosmetic and Laser Therapy. 2011 Mar 14
• 9 citations
  A phase IIa open-label dose-escalation pilot study using allogeneic human dermal fibroblasts for nasolabial folds.
  Nicholas J. Lowe, Philippa Lowe, John St Clair Roberts> ;Dermatologic Surgery. 2010 Oct 1
• 25 citations
  Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
  Nicholas J. Lowe, Aadarsh Shah, Philippa Lowe, Rickie Patnaik> ;Journal of Cosmetic and Laser Therapy. 2010 Mar 23
• 51 citations
  A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles
  Rhoda S. Narins, Leslie Baumann, Fredric S Brandt, Steven Fagien, Scott Glazer, Nicholas J. Lowe, Gary D. Monheit, Marta I. Rendon, Rod J. Rohrich, Wm. Philip Werschler> ;Journal of the American Academy of Dermatology. 2010 Mar 1
• 54 citations
  Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies
  Peter Foley, Michael Freeman, Alan Menter, Gregory Siller, Rokea A. el-Azhary, Kurt Gebauer, Nicholas J. Lowe, Michael Jarratt, Dedee F. Murrell, Phoebe Rich, David M....> ;International Journal of Dermatology. 2009 Nov 1
• 36 citations
  Injectable poly-L-lactic acid for cosmetic enhancement: Learning from the European experience
  Kimberly Butterwick, Nicholas J. Lowe> ;Journal of the American Academy of Dermatology. 2009 Aug 1
• 29 citations
  Injectable poly-l-lactic acid: 3 years of aesthetic experience.
  Nicholas J. Lowe, C. Anne Maxwell, Philippa Lowe, Ardash Shah, Rickie Patnaik> ;Dermatologic Surgery. 2009 Feb 2
• 34 citations
  Comparisons among botulinum toxins: an evidence-based review.
  Arnold William Klein, Alastair Carruthers, Steven Fagien, Nicholas J. Lowe> ;Plastic and Reconstructive Surgery. 2008 Jun 1
• 20 citations
  Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis.
  Paul S. Yamauchi, Nicholas J. Lowe> ;International Journal of Dermatology. 2008 Feb 1
• 7 citations
  Current and emerging therapeutic modalities for hyperhidrosis, part 2: moderately invasive and invasive procedures.
  Ramin Ram, Nicholas J. Lowe, Paul S. Yamauchi> ;Cutis. 2007 Apr 1
• 12 citations
  Current and emerging therapeutic modalities for hyperhidrosis, part 1: conservative and noninvasive treatments.
  Ramin Ram, Nicholas J. Lowe, Paul S. Yamauchi> ;Cutis. 2007 Mar 1
• 9 citations
  Facial aesthetics: Achieving the natural, relaxed look
  Alastair Carruthers, Joel L Cohen, Sue Ellen Cox, Koenraad De Boulle, Steven Fagien, Charles J. Finn, Timothy C. Flynn, Nicholas J. Lowe, Hervé Raspaldo, Boris Sommer,...> ;Journal of Cosmetic and Laser Therapy. 2007 Jan 1
• 6 citations
  Overview of botulinum neurotoxins.
  Nicholas J. Lowe> ;Journal of Cosmetic and Laser Therapy. 2007 Jan 1
• 9 citations
  3D photography and lip filler: a novel assay.
  Philippa Lowe, Nicholas J. Lowe> ;Journal of Cosmetic and Laser Therapy. 2007 Jan 1
• Join now to see all

Journal Articles

• Spot of Bother  
  Lowe N J, Lowe P L, Aesthetic Medicine, 1/1/2016
• Botulinum Type B; pH change reduces injection pain, retains efficacy  
  Lowe P L, Lowe N J, J. Dermatologic Surgery, 1/1/2014
• Botulinum Toxins for Facial Lines: A Concise Review  
  Lowe N J, Lowe P L, J Dermatol Therapy, 1/1/2012
• Three-dimensional digital surface imaging measurement of the volumizing effect of injectable poly-l-lactic acid for nasolabial folds  
  Lowe N.J., Lowe P.L., Patnaik R, J. Cos. Las. Ther., 1/1/2011
• Dosing, efficacy and safety plus the use of computerized photography for bolulinum toxins type A for upper facial lines  
  Lowe N J, Shah A, Lowe P, Patnaik R, Journal of Cosmetic and Laser Therapy, 1/1/2010
• A phase 11A open-label dose-escalation pilot study using allogeneic human dermal fibroblasts for nasolabial folds  
  Lowe N J, Lowe P L, St Clair Roberts J, Derm Surg, 1/1/2010
• Optimizing poly-L-lactic acid use  
  Lowe NJ, Journal of Cosmetic and Laser Therapy, 1/1/2008
• 3D Photography and lip filler: a novel assay  
  Lowe P, Lowe N, Journal of Cosmetic and Laser Therapy, 1/1/2007
• An overview of ultraviolet radiation, sunscreens and photo-induced dermatoses  
  Lowe NJ, Dermatol Clin, 1/1/2006
• Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis  
  Yamauchi PS., Lowe NJ, J. Am. Acad. Dermatol., 1/1/2006
• Treatment of recurrent Sweet’s syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept  
  Yamauchi PS., Turner L, Lowe NJ et al, J. Am. Acad. Dermatol., 1/1/2006
• Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept  
  Yamauchi PS., Lowe NJ, Gindi V, J. Am. Acad. Dermatol., 1/1/2006
• Light-emitting diode 415 nm in the treatment of inflammatory acne: an open-label, multicentric, pilot investigation  
  Tremblay JF, Sire DJ, Lowe NJ, Moy RL, Journal of Cosmetic and Laser Therapy, 1/1/2006
• Dispelling the myth: appropriate use of poly-L-lactic acid and clinical considerations and introductory comment  
  Lowe NJ, JEADV, 1/1/2006
• Tazorotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study  
  Lowe NJ, Horwitz S, Tanghetti E, Draelos Z and Menter A, Journal of Cosmetic and Laser Therapy, 1/1/2006
• Comparison of Two Formulations of Botulinum Toxin Type A for the Treatment of Glabellar Lines: A Double-Blind, Randomized Study  
  Lowe P, Patnaik R, Lowe NJ, J. Am. Acad. Dermatol., 1/1/2006
• Injectable hyaluronic acid implant for malar and mental enchancement  
  Lowe NJ, Grover R, Dermatol Surg, 1/1/2006
• Long term efficacy and safety of Tretinoin Emollient Cream 005% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial  
  Kang S, Bergfeld W, Gottlieb AB, Hickman J, Humeniuk J, Kempers S, Lebwohl M, Lowe N et al, American Journal of Clinical Dermatology, 1/1/2005
• Pilot study to determine the efficacy of ALA-PDT photorejuventation for the treatment of facial ageing  
  Lowe N J, Lowe P, Journal of Cosmetic Laser Therapy, 1/1/2005
• Adverse reactions to dermal fillers: a review of European experiences  
  Andre P, Lowe NJ, Parc A, Clerici TH, Zimmermann U, Journal of Cosmetic Laser Therapy, 1/1/2005
• A comparison of two Botulinum Type A Toxin Preparations for the Treatment of Glabellar Lines: Double-blind, randomized, pilot study  
  Lowe P, Patnaik R, Lowe N J, Dermatologic Surgery, 1/1/2005
• Pilot study to determine the efficacy of ALA-PDT photo-rejuvenation for the treatment of facial ageing  
  Lowe NJ, Lowe P, J. Cosmet Laser Therapy, 1/1/2005
• Cosmetic uses of botulinum toxins for lower aspects of the face and neck  
  Lowe NJ, Yamauchi P, Clinics in Dermatology, 1/1/2004
• Tazarotene 01% cream versus Tretinoin 005% emollient cream in the treatment of photodamaged facial skin: a multicentrer, double-blind, randomised, parallel-group study  
  Lowe NJ, Gifford M, Tanghetti E, Poulin YP, Goldman M, TseY, Yamauchi P, Rosenweig H and Kang S, Journal of Cosmetic and Laser Therapy, 1/1/2004
• Topical photodynamic therapy in clinical dermatology  
  Kormeill T, Yamauchi PS, Lowe NJ, British Journal of Dermatology, 1/1/2004
• Join now to see all

Books/Book Chapters

• Perfectly Clear; The Perfect Guild To Perfectly Clear Skin 
  Lowe N2016
• Away With Wrinkles 
  Lowe N2008
• Soft Tissue Augmentation 
  Chapter: Synthetic fillers: carboxymethyl cellulose, polyethylene oxide dermal filler 
  Page 163.0 - 167.0Lowe PL, Falcone S, Berg R, Lowe NEditors: Carruthers J and A.Churchill Livingston/ElsevierEdition 2nd,2007
• Psoriasis - A Patient Guide 
  Lowe NMartin Dunitz, LondonEdition 3rd,2004
• Handbook of Botulinum Toxin Treatment 
  Chapter: Cosmetic Indications 
  Boris Summer and Nick LoweEditors: Peter Moore and Markus Naumann.Edition 2nd,2003
• Facial Rejuvenation: Combination Minimally Invasive Treatments 
  Lowe NMartin Dunitz, London2001
• Skin Secrets – Medical Facts v Beauty Fiction 
  Lowe NCollins and Brown, London1999
• Psoriasis - A Patient Guide 
  Lowe NMartin Dunitz, LondonEdition 2nd,1998
• Patient Care 
  Chapter: Managing Acne In Adult Women 
  Page 30.0 - 32.0Lowe NJEditors: J Forster.1997
• Retinoids for the Clinician 
  Lowe NMartin Dunitz, LondonEdition 2nd,1997
• Sunscreens: Development, Evaluation and Regulatory Aspects 
  Lowe NMarcel DekkerEdition 2nd,1996
• Lasers in Cutaneous and Costmetic Surgery 
  Lowe NChurchill Livingstone, NY, London1996
• Retinoids for the Clinician 
  Lowe NMartin Dunitz, London1994
• Managing Your Psoriasis 
  Lowe NMaster Media, New York1993
• Practical Psoriasis Therapy 
  Lowe NMosby YearBook, New YorkEdition 2nd,1992
• Practical Psoriasis Therapy 
  Chapter: The Differential diagnosis of Psoriasis 
  Page 1.0 - 6.0Lowe NJMosby YearBookEdition 2nd,1992
• Practical Psoriasis Therapy 
  Chapter: The Psoriasis Patient: Selection of Therapy 
  Page 13.0 - 22.0Lowe NJ, Kingston T PMosby YearBookEdition 2nd,1992
• Practical Psoriasis Therapy 
  Chapter: Tars, Keratolytics, and Emmolients 
  Page 45.0 - 58.0Lowe NJMosby YearBookEdition 2nd,1992
• Practical Psoriasis Therapy 
  Chapter: Anthralin Therapy of Psoriasis 
  Lowe NJMosby YearBookEdition 2nd,1992
• Practical Psoriasis Therapy 
  Chapter: New Trends in Topical Psoriasis 
  Page 73.0 - 76.0Lowe NJMosby YearBookEdition 2nd,1992
• Practical Psoriasis Therapy 
  Chapter: Home Ultraviolet Phototherapy 
  Page 115.0 - 120.0Lowe NJMosby YearBookEdition 2nd,1992
• Practical Psoriasis Therapy 
  Chapter: Psoralen Ultraviolet A (PUVA) Therapy: Systemic Psoralens 
  Page 121.0 - 136.0Lowe NJMosby YearBookEdition 2nd,1992
• Practical Psoriasis Therapy 
  Chapter: Water Delivery of 8-Methoxypsoralen for Therapy with Psoralen and Ultraviolet A Phototherapy (PUVA) 
  Page 137.0 - 142.0Lowe NJMosby YearBookEdition 2nd,1992
• Practical Psoriasis Therapy 
  Chapter: Photoprotection and Sunscreen Use for patients receiving Psoralen and and Ultraviolet A Phototherapy (PUVA) 
  Page 143.0 - 154.0Lowe NJMosby YearBookEdition 2nd,1992
• Practical Psoriasis Therapy 
  Chapter: Synthetic Retinoid Therapy for Psoriasis 
  Page 165.0 - 176.0Lowe NJMosby YearBookEdition 2nd,1992
• Join now to see all

Abstracts/Posters

• An open-label dose-escalation study of allogeneic human fibroblasts administered intradermally to enhance the aesthetic appearance of nasolabial folds
  Lowe N, Lowe P, Patnaik R, St Clair Roberts J, American Academy of Dermatology annual meeting, San Francisco, 1/1/2009
• Low doses of repetitive ultraviolet A induce morphologic changes in human skin
  Lowe N, Meyers D, Weider J, Luftman D, Borget T, Lehman M, Johnson A, Scott I, Clinical Dermatology, Retinoids and Other Treatments, 1/1/2009
• Botulinum A exotoxin for glabella folds: a double-blind, placebo-controlled study with an electromyographic injection technique
  Lowe N, Maxwell A, Harper H, Clinical Dermatology, Retinoids and Other Treatments, 1/1/2009
• Volumizing effect of Poly-L-Lactic acid as measured by 3-dimenstional digital surface imaging
  Lowe N, Lowe P, Patnaik R, 66th Annual Meeting of the AAD, Texas, 1/1/2008
• Comparison of two formulations of Botulinum Toxin Type A for the treatment of Glabellar Lines: a double-blind, radomised study
  Lowe P, Patnaik R, Lowe N, International Conference on Neurotoxins, New York, 1/1/2007
• Comparison of two formulations of Botulinum Toxin type A for the treatment of Glabellar Lines: a double-blind, randomized study
  Lowe P, Patnaik R, Lowe NJ, European Masters in Aesthetic and Anti-Ageing Medicine (EMAA), Paris, 1/1/2007
• Poly-L-Lactic acid for volume replacement: an extended case review of 221 patients
  Lowe N, Maxwell A, Patnaik R, Shah A, American Society of Dermatology Surgery, 1/1/2007
• Botulinum Toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety
  Lowe NJ, Glaser DE, Eadie N, Daggett S, Kowalski JW, Lai PY and the North American Botox in primary axillary hyperhidrosis clinical study group, American Academy of Dermatology, 1/1/2007
• Comparison of Two Formulations of Botulinum Toxin Type A for the Treatment of Glabellar Lines: A double-blind, randomised study
  Lowe PL, Patnaik R, Lowe NJ, EMAA congress (European Masters in Aesthetic and Anti-Aging Medicine), 1/1/2007
• A comparison of two formulations of Botulinum Type A Toxin Preparations for the Treatment of Glabellar Lines: Double-blind, randomized study
  Lowe P, Patnaik R, Lowe N J, AAD, 1/1/2006
• Patients self-perception of age after Botulinum Toxin Type A treatment of upper facial rhytids: results across multiple clinical studies
  Carruthers A, Carruthers J, Cox SE, Fagien S, Finn JC, Kowalski JW, Lowe N, Ravelo A, Stotland MA, Werschler P, AAD, San Diego, 1/1/2006
• BoNTA for the treatment of Glabellar Lines
  Lowe Pl, Patnaik R, Lowe NJ Lowe, International Conference of Neurotoxins, Florida, 1/1/2006
• Comparision of two formulations of Botulinum Toxin Type A (BoNT/A) for the treatment of Glabellar lines a double-blind, randomized study
  Lowe NJ, Lowe P, Patnaik R, Lowe P, Nerotoxicity Research, 1/1/2006
• Comparision of Botox and Dysport for the treatment of Glabellar Lines: a double-blind, randomized study
  Lowe NJ, Lowe P, Patnaik R, EMAA, Paris, 1/1/2006
• Comparison of two formulations of Botulinum Toxin type A for the treatment of Glabellar Lines: a double-blind, randomized study
  L, Patnaik R, Lowe NJ, 29th Hawaii Dermatology Seminar, 1/1/2005
• Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of Botulinum Toxin type A in subjects with Crow;s Feet
  Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N on behalf of the Botox Facial Aesthetics Study Team, Dermatologic Surgery, 1/1/2005
• Comparison of two formulations of botulinum toxin type A (BoNTA) for the treatment of glabellar lines: a double-blind, randomized study
  Lowe NJ, Patnaik R, Lowe P, Toxins 2005 Meeting, Denver, 1/1/2005
• Treatment of coexisting bullous pemphigold and psoriasis with the tumor necrosis factor antagonist etanercept
  Yamauchi PS, Lowe NJ, Gindi V, Journal American Academy Dermatology, 1/1/2005
• Treatment of Sweet’s Syndrome in a patient with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept
  Yamauchi PS, Lowe NJ, Gindi V, Journal American Academy Dermatology, 1/1/2005
• Patient self-perceptions and satisfactions with Botulinum Toxin Type A treatment for moderate to severe crow’s feet: results from a placebo-controlled clinical study
  Kowalski J, Ravelo A, Saulay M, Fraczek S, Eadie N, Lowe J, American Academy of Dermatology, 1/1/2005
• Botulinum Toxin Type-A improves occupational impairment associated with primary axillary hyperhidrosis and results in high levels of satisfaction with treatment
  Glaser DA, Solish N, Naumann MK, Hamm H, Lowe NJ, Benohanian A, Kowalski JW, Clinical Dermatology Conference, 1/1/2005
• Tazarotene 0.1% cream versus Tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study
  Lowe NJ, Kang S, Tanghetti E, Poulin Y, Goldman M, Tse Y, Yamauchi P, Rosenzweig H, AAD Annual Meeting, 1/1/2004
• Botulinum Toxin Type-A Improves Occupational Impairment Associated with Primary Axillary Hyperhidrosis and results in high levels of satisfaction with treatment
  Glaser DA, Solish N, Naumann MK, Hamm H, Lowe NJ, Kowalski JW, AAD Scientific Exhibit 2004 Summer Meeting, 1/1/2004
• 4-year review of Restylane/Perlane Dermal Fillers
  Lowe NJ, Maxwell CA, ASDS-ACMMSCO Combined Annual Meeting, San Diego, 1/1/2004
• Topical Tazarotene Meta-Analysis in Acne Vulgaris
  Leyden JJ, Lowe NJ, Shalita A, Webster G, AAD Annual Meeting, 1/1/2004
• Join now to see all

Lectures

• Development and improved delivery of injectabls including Botulinum Toxin and Fillers 
  Los Angeles - 1/1/2017
• Injectable Neocollagenesis 
  1/1/2016
• Applications and delivery of Neurotoxins in dermatgology 
  1/1/2016
• Non-invasive body contouring 
  1/1/2015
• Fillers lift and Fill, BTX AandB Benefits and problems, Fractional RF V Frac Laser 
  Cannes - 1/1/2015
• Injectable Workshop on Neurotoxins 
  London - 1/1/2014
• Filler Workshop 
  London - 1/1/2014
• Advanced Clinic Techniques for Facial Volumisation 
  Los Angeles - 1/1/2014
• Expert Discussion 
  Los Angeles - 1/1/2014
• Finessing Facial Fillers 
  London - 1/1/2014
• Surgical Scars 
  Glasgow - 1/1/2014
• Botox Complications and Benefits 
  1/1/2014
• Fillers and Radiofrequency 
  1/1/2014
• Cosmetic uses and Complications of Botulinum Toxin 
  1/1/2014
• A Day with Dr Nick Lowe 
  1/1/2013
• Botox Pearls 
  London - 1/1/2013
• Facial Contouring with Dermal Filler 
  California - 1/1/2013
• Radiofrequency Scars 
  1/1/2013
• Volumising Fillers 
  Cannes - 1/1/2013
• Rejuvenation of the lower face using Botox 
  1/1/2013
• The Botox 2013 
  1/1/2013
• Finessing Fillers 
  1/1/2013
• Efficacy and Safety update, psycho-dermatology in psoriasis 
  1/1/2012
• Dermatological surgery 
  1/1/2012
• Fillers Good and Bad 
  Miami - 1/1/2011
• Join now to see all

Other

• Three-dimensional digital Surface Imaging Measurement of the Volumizing effect of injectable poly-l-lactic acid for Nasolabial folds 
  Lowe N J, Taylor and Francis on line publication
  1/1/2015
• The Noughties …… was that it – comments on Tanning and Botox 
  Lowe N, BBC 3
  1/1/2009
• 5-MOP-bathwater delivery trends to watch in PUVA 
  Lowe NJ, Dermatology Times
  1/1/1993
• Recent Advances in the Therapy of Psoriasis 
  Lowe N
• Psoriatic Arthritis 
  Lowe N, Lifetime Medical Television
• PUVA Therapy for Psoriasis 
  Lowe N, Teaching VCR Tape
• Alopecia 
  Lowe N, Network for Continuing Medical Education
• Synthetic Retinoids in Psoriasis 
  Lowe N, Visual Information System, Inc/NBC Nightly News
• Etretinate for Severe Psoriasis: How and When to Use It 
  Lowe N, Visual Information Systems, Inc
• Diagnosis and Management of Alopecia 
  Lowe N, Visual Information Systems, Inc
• Retinoids and Therapy for Psoriasis 
  Lowe N, Visual Information Systems, Inc
• Sunlight and Skin Cancer 
  Lowe N, Today Show
• Topical Retinoids, Photoaging 
  Lowe N, Lifetime Medical Television
• Dye Laser Therapy for Hemangiomata 
  Lowe N, Channel 2 News
• Dermatology for the Practitioner 
  Lowe N, NCME
• Topics in Dermatology 
  Lowe N, Lifetime Medical Television
• Laser Therapy of Vascular Skin Lesions 
  Lowe N, NBC Nightly News
• PUVA Phototherapy - A Teaching Video for Physicians and Patients 
  Lowe N
• Advances in Psoriasis Therapy 
  Lowe N, NBC Nightly News
• New Sunscreens 
  Lowe N, NBC Nightly News
• Tanning 
  Lowe N, Entertainment Tonight
• Adult Female Acne 
  Lowe N, ABC Home Show
• Update On Psoriasis 
  Lowe N, Current Health Views in Medicine – Video Cable Network
• Photoprotection 
  Lowe N, Current Health Views in Medicine
• Photodamage 
  Lowe N, Medi Cine International
  London
• Join now to see all